Evaluation of Medical and Social Care for Elderly Patients, Between Hospital and Home: TEMPORARY ACCOMMODATION Out of Hospitalization by Nursing Home and Long-Term Care Units in Ile-de-France Region
HTSH
1 other identifier
observational
258
1 country
10
Brief Summary
Prospective, observational, non-interventional, comparative, multicenter RIPH3 study to investigate the impact of HTSH on length of hospital stay in referring services.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2024
Typical duration for all trials
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2024
CompletedFirst Posted
Study publicly available on registry
November 7, 2024
CompletedStudy Start
First participant enrolled
November 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 20, 2027
June 13, 2025
June 1, 2025
2 years
October 23, 2024
June 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Study to investigate the impact of HTSH on length of hospital stay in referring services
The main assessment criterion is based on the average length of stay observed at the end of the study, compared with that of the previous two years, 2021 and 2022, in the referring services.
24 months
Secondary Outcomes (4)
Analysis of pathways and plans for returning home
24 months
Analysis of HTSH patient profiles a) Proportion of eligible patients and their comorbidities b) Social profile + main reason for hospitalization of patients admitted to HTSH
24 months
Analysis of discharges and patient outcomes
24 months
Quality of life and caregiver benefit analysis
24 months
Study Arms (2)
Prospective group
258 subjects in the prospective group
Retrospective group
Retrospective data will be collected directly from hospital departments by ARS IDF or from physicians responsible for medical information (RMI) within each hospital center participating in the study, for the 2 years 2021 and 2022 prior to the study and compared with the average length of stay for services to be calculated at the end of the study.
Eligibility Criteria
258 subjects in the prospective group. Retrospective data will be collected directly from hospital departments by ARS IDF or from physicians responsible for medical information (RMI) within each hospital center participating in the study, for the 2 years 2021 and 2022 prior to the study and compared with the average length of stay for services to be calculated at the end of the study.
You may qualify if:
- Patient selection criteria
- Patient male or female at least 60 years of age, as initially defined with the Regional Health Agency, discharged from hospital,
- Oral expression of non opposition to participation in the study, documented in the medical record by the physician,
- Presenting a defined and feasible plan for returning home,
- Whose social/medical situation (stabilized) does not allow an immediate return home after hospitalization.
- Caregiver selection criteria
- Person with an unpaid caregiving activity for their relative in HTSH,
- Person verbally expressing their non-opposition to participating in the study, and documented in the medical record of the patient they are helping,
- A person who is able to understand the study questionnaires and evaluations, and is able to answer them without the help of a third party.
- Professional selection criteria
- Salaried professional, nursing or not, regularly and directly involved in the HTSH circuit, whether in hospital or in nursing home / long term care units, for at least 6 months,
- Oral expression of non opposition to participation in the study, documented by the establishment.
- Be already included in another clinical study,
- Benefit from a legal protection measure or be unable to express their consent, in accordance with article L1121-8 of the French Public Health Code.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gérond'iflead
Study Sites (10)
Résidence ZEMGOR
Cormeilles-en-Parisis, 95240, France
EHPAD Pierre TABANOU
L'Haÿ-les-Roses, 94240, France
Groupe Hospitalier Sud Ile de France (GHSIF)
Melun, 77000, France
GHU Lariboisière
Paris, 75010, France
Broca Hospital
Paris, 75013, France
USDL Vaugirard, APHP
Paris, 75015, France
Centre Hospitalier de Rambouillet
Rambouillet, 78514, France
Centre Hospitalier de Versailles
Versailles, 78157, France
Hopital Paul Brousse
Villejuif, 94800, France
CHU Bicêtre
Paris, Île-de-France Region, 94270, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2024
First Posted
November 7, 2024
Study Start
November 20, 2024
Primary Completion (Estimated)
November 20, 2026
Study Completion (Estimated)
November 20, 2027
Last Updated
June 13, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE